Tanzania - English - Tanzania Medicinces & Medical Devices Authority

shelys pharmaceuticals limited, tanzania - quinine - tablets - 300 mg

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

remedica ltd, cyprus - quinine - tablets - 300 mg

Uganda - English - National Drug Authority

elys chemical industries ltd - quinine sulphate - oral solid ordinary other coated tablets - 300mg

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875 gpo 00100 nairobi kenya - quinine sulphate - tablet - 300mg per tablet - other antimalarial antiprotozoals

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875 gpo 00100 nairobi kenya - quinine bisulphate - syrup - 50mg per 5ml - other antimalarial antiprotozoals

United States - English - NLM (National Library of Medicine)

riconpharma llc - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg

United States - English - NLM (National Library of Medicine)

corepharma, llc - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg - qualaquin is an antimalarial drug indicated only for treatment of uncomplicated plasmodium falciparum malaria. quinine sulfate has been shown to be effective in geographical regions where resistance to chloroquine has been documented [see clinical studies (14) ]. limitations of use: qualaquin is not approved for: qualaquin is contraindicated in patients with the following: risk summary prolonged experience with quinine in pregnant women over several decades, based on published prospective and retrospective observational studies, surveys, safety and efficacy studies, review articles, case reports and case series have not identified a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes (see data) . in animal reproduction studies, administration of quinine by multiple routes of administration to pregnant rabbits, dogs, guinea pigs, rats, and monkeys during the period of organogenesis at doses of 0.25 to 2 times the maximum recommended human dose (mrhd) based on body su